18 Amendments of Cristian-Silviu BUŞOI related to 2018/0225(COD)
Amendment 85 #
Proposal for a decision
Article 5 – paragraph 1 – introductory part
Article 5 – paragraph 1 – introductory part
1. For each mission, a mission board may be established. ItThe mission board will connect to a high-level panel tasked with ensuring a comprehensive research strategy in the broader field, such as in health. The mission board shall be composed of around 15 high level individuals including relevant end-users' representatives. The mission board shall advise upon the following:
Amendment 94 #
Proposal for a decision
Article 11 – paragraph 1 – point 1 (new)
Article 11 – paragraph 1 – point 1 (new)
(1) Missions will be defined through the high-level panel tasked with ensuring a comprehensive research strategy in the broader field of 'Challenges', such as in Health.
Amendment 97 #
Proposal for a decision
Article 11 – paragraph 2 – introductory part
Article 11 – paragraph 2 – introductory part
2. The Commission shall adopt separate work programmes, by means of implementingdelegated acts, for the implementation of actions under the following components, as set out in Article 3(1) of this Decision :
Amendment 120 #
Proposal for a decision
Annex I – part II – point 1 – point 1.1 – paragraph 3
Annex I – part II – point 1 – point 1.1 – paragraph 3
Health research and innovation research and innovation have played a significant part in this achievement but also in improving productivity and quality in the health and care industry. However, the EU continues to face novel, newly emerging or persisting challenges that are threatening its citizens and public health, the sustainability of its health care and social protection systems, as well as the competitiveness of its health and care industry. Major health challenges in the EU include: the lack of effective health promotion and disease prevention; the rise of non-communicable diseases; the spread of antimicrobial drug resistance and the emergence of infectious epidemics; increased environmental pollution; the persistence of health inequalities among and within countries affecting disproportionally people that are disadvantaged or in vulnerable stages of life; the earlier detection, understanding, and control,; prevention and mitigation at population level of health risks in a rapidly changing social, urban and natural environment; the increasing costs for European health care systems and the progressive introduction of personalised medicine approaches and digitalisation in health and care; and the increasing pressure on the European health and care industry to remain competitive in and by developing health innovation vis-a-vis new and emerging global players.
Amendment 121 #
Proposal for a decision
Annex I – part II – point 1 – point 1.1 – paragraph 3 a (new)
Annex I – part II – point 1 – point 1.1 – paragraph 3 a (new)
In the EU, 550 000 people in working age die from four major chronic diseases (cardiovascular disease, cancers, respiratory diseases and diabetes) every year. This carries a significant societal and economic cost. OECD has estimated that losing 550 000 productive lives costs the EU economy € 115 billion a year. This corresponds to 0.8% of GDP in the EU.
Amendment 125 #
Proposal for a decision
Annex I – part II – point 1 – point 1.1 – paragraph 5 a (new)
Annex I – part II – point 1 – point 1.1 – paragraph 5 a (new)
Activities under this cluster may be implemented through a Union partnership with industry.
Amendment 127 #
Proposal for a decision
Annex I – part II – point 1 – point 1.1 – point i (new)
Annex I – part II – point 1 – point 1.1 – point i (new)
(i) Health research provides the knowledge basis for more healthy people and for better patient care. Health research has unique features, connecting and interacting closely with health care and innovation, and operating in a multidisciplinary environment with complex regulations. Health research delivers societal value beyond financial return.
Amendment 128 #
Proposal for a decision
Annex I – part II – point 1 – point 1.1 – point ii (new)
Annex I – part II – point 1 – point 1.1 – point ii (new)
(ii) A High-Level group will support achieving these aims, namely, the Steering Board for Health. It shall ensure coordination and synergies of health research programs in other Challenges e.g. 'Digital' and in related pillars, such as with EIC, ERC, as well as within Strategic Partnerships. It will be science- led and include all stakeholders, with strong participation of society, citizens and patients. It will be tasked to provide steering/advice in developing the work programme and missions related to Health. Aligning health research programs and co-design with society will enhance the societal impact and reduce waste.
Amendment 129 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.1 – paragraph 2 – indent 1 a (new)
Annex I – part II – point 1 – point 1.2 – point 1.2.1 – paragraph 2 – indent 1 a (new)
– Well-designed public health interventions for reducing the burden and impact of infections throughout the life cycle
Amendment 131 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.1 – paragraph 2 – indent 4 a (new)
Annex I – part II – point 1 – point 1.2 – point 1.2.1 – paragraph 2 – indent 4 a (new)
– Health consequences derived from vaccine hesitancy
Amendment 133 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.2 – paragraph 1
Annex I – part II – point 1 – point 1.2 – point 1.2.2 – paragraph 1
Improved understanding of health drivers, determinants of health and risk factors determined by the social, economic and physical environment in people’s everyday life and at the workplace, including the health impact of digitalisation, pollution, climate change and other environmental issues, will contribute to improve disease prevention, identify and mitigate health risks and threats; to reducing death and illness from exposure to chemicals and environmental pollution; to supporting environmental-friendly, healthy, resilient and sustainable living and working environments; to promoting healthy lifestyles andincluding through tobacco control measures, consumption behaviour; and to developing an equitable, inclusive and trusted society.
Amendment 139 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.3 – paragraph 1
Annex I – part II – point 1 – point 1.2 – point 1.2.3 – paragraph 1
Non-communicable diseases (NCDs), including rare diseases, pose a major health and societal challenge and call for more effective approaches inpopulation level approaches in primary and secondary prevention, treatment and cure, including with policy research and personalised medicine approaches.
Amendment 145 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.3 – paragraph 2 a (new)
Annex I – part II – point 1 – point 1.2 – point 1.2.3 – paragraph 2 a (new)
Priority will be given to those projects in the area of diseases were national activities or plans alone cannot achieve effectiveness or where European action can significantly impact outcomes.
Amendment 146 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.4 – paragraph 1
Annex I – part II – point 1 – point 1.2 – point 1.2.4 – paragraph 1
Protecting people against cross-border health threats is a major challenge for public health, calling for effective international cooperation at EU and global level. This will involve prevention, including vaccination, preparedness, early detection, treatment and cure of infectious diseases, and also tackling antimicrobial resistance (AMR) following a 'One Health approach'.
Amendment 151 #
– Vaccines, dDiagnostics, treatments and cures for infectious diseases, including co- morbidities and co-infections;
Amendment 154 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.4 – paragraph 2 – subparagraph 1 (new)
Annex I – part II – point 1 – point 1.2 – point 1.2.4 – paragraph 2 – subparagraph 1 (new)
Suitable, safe and efficient vaccines for prevention and prophylaxis of infectious diseases, including research and discovery of novel vaccine, advance immunization technologies and regulatory sciences;
Amendment 200 #
Proposal for a decision
Annex I – part II – point 5 – introductory part
Annex I – part II – point 5 – introductory part
5. CLUSTER 'FOOD, ENVIRONMENT AND NATURAL RESOURCES'
Amendment 203 #
Proposal for a decision
Annex I – part II – point 5 – point 5.1 – paragraph 8
Annex I – part II – point 5 – point 5.1 – paragraph 8
Activities will contribute directly to the following Sustainable Development Goals (SDGs) in particular: SDG 2 – Zero Hunger; SDG 3 – Good Health And Wellbeing; SDG 6 -– Clean Water and Sanitation; SDG 11 – Sustainable Cities and Communities; SDG 12 -– Responsible Consumption and Production; SDG 13 – Climate Action; SDG 14 – Life Below Water; SDG 15 -– Life on Land.